Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy-Reference-Cited by-同舟云学术

Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy

Published:2003-06-24 Issue:1 Volume:92 Page:19-23
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Brandli D.W.,Koch M.O.,Foster R.S.,Bihrle R.,Gardner T.A.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1464-410X.2003.04269.x/fullpdf

Reference8 articles.

1. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate;Stamey;J Urol,1998

2. Ability of preoperative serum prostate specific antigen value to predict pathological stage and DNA ploidy. Influence of clinical stage and tumor grade;Kleer;Urology,1993

3. The new American Committee on Cancer and International Union against Cancer TNM classification of prostate cancer;Ohori;Cancer,1994

4. Prostate-specific antigen after anatomic radical retropubic prostatectomy;Pound;Urol Clin North Am,1997

5. Defining prostate specific antigen progression after radical prostatectomy. What is the most appropriate cut point?;Amling;J Urol,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of very high initial PSA on oncological outcomes after radical prostatectomy for clinically localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2020-05

2. Radical prostatectomy for locally advanced and high-risk prostate cancer: A systematic review of the literature;Progrès en Urologie;2018-12

3. Treatment Outcomes in Non-Metastatic Prostate Cancer Patients With Ultra-High Prostate-Specific Antigen;International Journal of Radiation Oncology*Biology*Physics;2012-07

4. Debulking surgery in the setting of very high-risk prostate cancer scenarios;BJU International;2012-02-07

5. Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious;Urologic Oncology: Seminars and Original Investigations;2012-01